This title appears in the Scientific Report :
2023
Please use the identifier:
http://hdl.handle.net/2128/34030 in citations.
Please use the identifier: http://dx.doi.org/10.1007/s00415-022-11444-w in citations.
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
BackgroundA fraction of patients with asymptomatic to mild/moderate acute COVID-19 disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to assess the neuropsychological profile of these patients.MethodsAssessment at baseline (three months or more following acute...
Saved in:
Personal Name(s): | Schild, Ann-Katrin (Corresponding author) |
---|---|
Goereci, Yasemin (Corresponding author) / Scharfenberg, Daniel / Klein, Kim / Lülling, Joachim / Meiberth, Dix / Schweitzer, Finja / Stürmer, Sophie / Zeyen, Philip / Sahin, Derya / Fink, Gereon R. / Jessen, Frank / Franke, Christiana / Onur, Oezguer A. / Kessler, Josef / Warnke, Clemens / Maier, Franziska | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 |
Published in: | Journal of Neurology Journal of neurology, 270 (2022 2023) S. 1215-1223 |
Imprint: |
Berlin
Springer
2023
2022-11-23 |
DOI: |
10.1007/s00415-022-11444-w |
Document Type: |
Journal Article |
Research Program: |
Multilevel Brain Organization and Variability |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1007/s00415-022-11444-w in citations.
BackgroundA fraction of patients with asymptomatic to mild/moderate acute COVID-19 disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to assess the neuropsychological profile of these patients.MethodsAssessment at baseline (three months or more following acute COVID-19) of a monocentric prospective cohort of patients with post-COVID-19 syndrome. Multidomain neuropsychological tests were performed, and questionnaires on depression, anxiety, fatigue, sleep, and general health status were administered.ResultsOf the 58 patients screened, six were excluded due to possible alternative causes of cognitive impairment (major depression, neurodegenerative disease). Of the remaining 52 individuals, only one had a below-threshold screening result on Mini-Mental State Examination, and 13 scored below the cut-off on Montreal Cognitive Assessment. Extended neuropsychological testing revealed a neurocognitive disorder (NCD) in 31 (59.6%) participants with minor NCD in the majority of cases (n = 26). In patients with NCD, the cognitive domains learning/memory and executive functions were impaired in 60.7%, complex attention in 51.6%, language in 35.5%, and perceptual-motor function in 29.0%. Cognitive profiles were associated with daytime sleepiness but not with depression, anxiety, sleep quality, total general health status, or fatigue.ConclusionNeurocognitive impairment can be confirmed in around 60% of individuals with self-reported deficits as part of post-COVID-19 syndrome following a mild acute COVID-19 disease course. Notably, screening tests cannot reliably detect this dysfunction. Standard psychiatric assessments showed no association with cognitive profiles. Longitudinal studies are needed to further evaluate the course of neurocognitive deficits and clarify pathophysiology. |